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ABSTRACT 
 
Drug  Utilization  Study  of  Type 2  Diabetic  Patient  with  Nephropathy 
Complication (Study at Dr.Soetomo General Hospital Surabaya) 
 
 Diabetic nephropathy is  the most common cause of renal failure. The mortality 
rate from all causes in diabetic patients with nephropathy is 20-40 times higher than that 
of patients without nephropathy. In this study, the drug utilization profile on type  2 
diabetic patient with nephropathy was analyzed descriptively used patient’s medical 
records by retrospective method. The results showed that patients with type 2 diabetic 
nephropathy use either ACEIs,CCBs, ARBs, ACEI and diuretic, ACEI and CCB as their 
antihypertensive therapy; insulin to control blood  glucose  intensively;  the  third  
generation  cephalosporins  antibiotics  for urinary tract infection therapy; sodium 
bicarbonat, calsium carbonat or calsium gluconas for therapy of body electrolite 
imbalance; aspirin and dipiridamol as antiplatelet/haemoreology agents; H2 receptor 
antagonist as stress ulcer therapy;  
Packed Red Cell/PRC tranfusion as anemia therapy; allopurinol as hyperuricemia  
 therapy; etc. Drug therapy of type 2 diabetic patient with nephropathy is quite 
complicated because it depends on the clinical presentation of patient. Diabetic 
nephropathy needs some potential therapeutic strategies primarily in the treatment 
proteinuria with the ACEI and/or ARBs, intensive blood pressure control, and intensive 
blood glucose control to prevent the proteinuria progression and the renal function’s 
decline. Further study is needed to learn more  (dose, adverse drugs  reaction,  etc)  about  
drug  utilization  of  type 2  diabetic  patient  with  
 nephropathy.  
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